Bridgewater, MA -- (SBWIRE) -- 03/19/2013 -- Bridgewater, MA - The StockConsultant stock screener has found biotech stocks Dendreon Corporation (NASDAQ:DNDN) and Keryx Biopharmaceuticals (NASDAQ:KERX) at strong support with good upside trade quality and price targets.
Dendreon Corporation (NASDAQ:DNDN) founded in 1992 and headquartered in Seattle, WA is a biotechnology company which specializes in discovery, development and commercialization of novel pharmaceutical products for the potential treatment of a variety of cancers. DNDN over the past two months has pulled back to where it is today at strong triple support centered around the 5.39 price level. The stock is currently awaiting some bullish accumulation and has good upside trade quality with a price target T1 of 7.06.
DNDN abbreviated support and resistance areas:
CURRENT PRICE 5.35, at support, 5.39 ± 0.26, type triple+, strength 10
RESISTANCE ABOVE +12.7% at 6.03 ± 0.29, type triple, strength 10
+25.6% at 6.72 ± 0.32, type double, strength 10
SUPPORT BELOW -11% at 4.76 ± 0.23, type triple+, strength 10
-20% at 4.28 ± 0.21, type double, strength 6
DNDN upside trade details:
TRADE QUALITY 70%, Good
TARGET 1 Price: 7.06 Profit: 32% , for a typical rally.
Stop Limit/Trailing Stop Limit: 5.05 Loss: 5.6%
Profit/Loss Ratio: 5.7 : 1 - Excellent
Full DNDN stock report with charts and analysis
Keryx Biopharmaceuticals (NASDAQ:KERX) founded in 1998 and headquartered in New York, NY is a biopharmaceutical company that develops pharmaceutical products for the treatment of cancer and renal disease. KERX stock price over the past two months has been consolidating between 6.5 and 7.5. The stock over the past two weeks has made several attempts to break above the current resistance area centered at 7.14 and has excellent trade quality and price target T1 of 9.06.
KERX abbreviated support and resistance areas:
CURRENT PRICE 7.39, at resistance or support, 7.14 ± 0.35, type double, strength 10
RESISTANCE ABOVE +14.3% at 8.45 ± 0.41, type single, strength 8
SUPPORT BELOW -11% at 6.58 ± 0.32, type single, strength 3
-59.1% at 3.02 ± 0.15, type triple, strength 8
KERX upside trade details:
TRADE QUALITY 95%, Excellent
TARGET 1 Price: 9.06 Profit: 22.6% , for a typical rally.
Stop Limit/Trailing Stop Limit: 6.95 Loss: 6%
Profit/Loss Ratio: 3.8 : 1 - Excellent
Full KERX stock report with charts and analysis
StockConsultant.com provides automated stock consulting and advanced screener on over 6000 US equities. Each detailed stock report contains easy to use technical analysis indicators, charts, and news to fine tune stock entry and exit price levels.
StockConsultant.com and its employees are not registered investment advisors and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Please check with a registered investment advisor before making any investment decisions.
For our full disclaimer please visit: http://www.stockconsultant.com/disclaimerpage.html
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-321-1250 (International)